News

Thanks to all speakers and participants for this great first edition of the Cellular Allergy Innovation Forum at Basel Life 2019.

At this year`s 14th Dresden Symposium on Autoantibodies the diagnostic relevance of anti-HNK-1 antibodies has been presented for the first time.

We are very pleased to announce the United States Food and Drug Administration (FDA) 510(k) clearance for the BÜHLMANN CALEX® Cap.